Litcius/Paper detail

Immunogenicity and safety of a modified three-dose priming and booster schedule for the Hantaan virus vaccine (Hantavax): A multi-center phase III clinical trial in healthy adults

Joon Young Song, Hye Won Jeong, Jong Woo Yun, Jacob Lee, Heung Jeong Woo, Joon‐Yong Bae, Man‐Seong Park, Won Suk Choi, Dae Won Park, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim

2020Vaccine18 citationsDOI

Topics & Concepts

MedicineAdverse effectSeroconversionHantaan virusVaccinationImmunogenicityBooster doseImmunologyClinical trialInternal medicineAntibodyImmunizationVirusHantavirusViral Infections and VectorsViral Infections and Outbreaks ResearchVector-Borne Animal Diseases
Immunogenicity and safety of a modified three-dose priming and booster schedule for the Hantaan virus vaccine (Hantavax): A multi-center phase III clinical trial in healthy adults | Litcius